F2RL3
Appearance
Protease-activated receptor 4(PAR-4), also known ascoagulation factor II (thrombin) receptor-like 3,is aproteinthat in humans is encoded by theF2RL3gene.[5]
Function[edit]
Coagulation factor II (thrombin) receptor-like 3 (F2RL3) is a member of the large family of 7-transmembrane-region receptors that couple to guanosine-nucleotide-binding proteins. F2RL3 is also a member of theprotease-activated receptorfamily. F2RL3 is activated by proteolytic cleavage of its extracellularamino terminus.The new amino terminus functions as a tethered ligand and activates the receptor. F2RL3 is activated bythrombinandtrypsin.[5]
See also[edit]
References[edit]
- ^abcGRCh38: Ensembl release 89: ENSG00000127533–Ensembl,May 2017
- ^abcGRCm38: Ensembl release 89: ENSMUSG00000050147–Ensembl,May 2017
- ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ab"Entrez Gene: F2RL3 coagulation factor II (thrombin) receptor-like 3".
Further reading[edit]
- Leger AJ, Covic L, Kuliopulos A (2006)."Protease-activated receptors in cardiovascular diseases".Circulation.114(10): 1070–7.doi:10.1161/CIRCULATIONAHA.105.574830.PMID16952995.S2CID312800.
- Xu WF, Andersen H, Whitmore TE, et al. (1998)."Cloning and characterization of human protease-activated receptor 4".Proc. Natl. Acad. Sci. U.S.A.95(12): 6642–6.Bibcode:1998PNAS...95.6642X.doi:10.1073/pnas.95.12.6642.PMC22580.PMID9618465.
- Kahn ML, Zheng YW, Huang W, et al. (1998). "A dual thrombin receptor system for platelet activation".Nature.394(6694): 690–4.Bibcode:1998Natur.394..690K.doi:10.1038/29325.PMID9716134.S2CID4408582.
- Kahn ML, Hammes SR, Botka C, Coughlin SR (1998)."Gene and locus structure and chromosomal localization of the protease-activated receptor gene family".J. Biol. Chem.273(36): 23290–6.doi:10.1074/jbc.273.36.23290.PMID9722561.S2CID32777201.
- Kahn ML, Nakanishi-Matsui M, Shapiro MJ, et al. (1999)."Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin".J. Clin. Invest.103(6): 879–87.doi:10.1172/JCI6042.PMC408153.PMID10079109.
- Andersen H, Greenberg DL, Fujikawa K, et al. (1999)."Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity".Proc. Natl. Acad. Sci. U.S.A.96(20): 11189–93.Bibcode:1999PNAS...9611189A.doi:10.1073/pnas.96.20.11189.PMC18009.PMID10500152.
- Sambrano GR, Huang W, Faruqi T, et al. (2000)."Cathepsin G activates protease-activated receptor-4 in human platelets".J. Biol. Chem.275(10): 6819–23.doi:10.1074/jbc.275.10.6819.PMID10702240.S2CID33219053.
- Nakanishi-Matsui M, Zheng YW, Sulciner DJ, et al. (2000). "PAR3 is a cofactor for PAR4 activation by thrombin".Nature.404(6778): 609–13.Bibcode:2000Natur.404..609N.doi:10.1038/35007085.PMID10766244.S2CID4410800.
- Miike S, McWilliam AS, Kita H (2002)."Trypsin induces activation and inflammatory mediator release from human eosinophils through protease-activated receptor-2".J. Immunol.167(11): 6615–22.doi:10.4049/jimmunol.167.11.6615.PMID11714832.S2CID9302877.
- Asokananthan N, Graham PT, Fink J, et al. (2002)."Activation of protease-activated receptor (PAR)-1, PAR-2, and PAR-4 stimulates IL-6, IL-8, and prostaglandin E2 release from human respiratory epithelial cells".J. Immunol.168(7): 3577–85.doi:10.4049/jimmunol.168.7.3577.PMID11907122.S2CID45171728.
- Henriksen RA, Hanks VK (2002)."PAR-4 agonist AYPGKF stimulates thromboxane production by human platelets".Arterioscler. Thromb. Vasc. Biol.22(5): 861–6.doi:10.1161/01.ATV.0000014742.56572.25.PMID12006403.S2CID24246544.
- Covic L, Singh C, Smith H, Kuliopulos A (2003). "Role of the PAR4 thrombin receptor in stabilizing platelet-platelet aggregates as revealed by a patient with Hermansky-Pudlak syndrome".Thromb. Haemost.87(4): 722–7.doi:10.1055/s-0037-1613071.PMID12008957.S2CID32831294.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003)."Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences".Proc. Natl. Acad. Sci. U.S.A.99(26): 16899–903.Bibcode:2002PNAS...9916899M.doi:10.1073/pnas.242603899.PMC139241.PMID12477932.
- Owen WG (2003). "PAR-3 is a low-affinity substrate, high affinity effector of thrombin".Biochem. Biophys. Res. Commun.305(1): 166–8.doi:10.1016/S0006-291X(03)00732-0.PMID12732212.
- Adam F, Verbeuren TJ, Fauchère JL, et al. (2003)."Thrombin-induced platelet PAR4 activation: role of glycoprotein Ib and ADP".J. Thromb. Haemost.1(4): 798–804.doi:10.1046/j.1538-7836.2003.00138.x.PMID12871418.S2CID12762388.
- Wu CC, Hwang TL, Liao CH, et al. (2004). "The role of PAR4 in thrombin-induced thromboxane production in human platelets".Thromb. Haemost.90(2): 299–308.doi:10.1160/TH03-02-0103.PMID12888878.S2CID4983617.
- Kawai T, Akira S, Reed JC (2003)."ZIP kinase triggers apoptosis from nuclear PML oncogenic domains".Mol. Cell. Biol.23(17): 6174–86.doi:10.1128/MCB.23.17.6174-6186.2003.PMC180930.PMID12917339.
- Jacques SL, Kuliopulos A (2004)."Protease-activated receptor-4 uses dual prolines and an anionic retention motif for thrombin recognition and cleavage".Biochem. J.376(Pt 3): 733–40.doi:10.1042/BJ20030954.PMC1223816.PMID13678420.
- Han Y, Nurden A, Combrié R, Pasquet JM (2004)."Redistribution of glycoprotein Ib within platelets in response to protease-activated receptors 1 and 4: roles of cytoskeleton and calcium".J. Thromb. Haemost.1(10): 2206–15.doi:10.1046/j.1538-7836.2003.00436.x.PMID14521606.S2CID24420859.
This article incorporates text from theUnited States National Library of Medicine,which is in thepublic domain.